Michael Burgess actually said...

bipartisanship is asking for my input, not just for my vote.

It is likely that legislation to address drug pricing will ruffle some feathers, and that is OK.

I will admit to being frustrated that we are not considering, perhaps, some additional policies.

And this is why we are very eager, particularly as we move toward much more expensive biotech drugs in the future to make sure that we are d...